Saturday 17 October 2026
Export AWIN’s income statement to Excel — free account
AERWINS Technologies Inc.
AWIN Technology Scientific & Technical Instruments
Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow AWIN
| Mar '24 | Dec '23 | Sep '23 | Jun '23 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
— | — | 9.33 | 13.13 | |
P/FCF ratio |
— | — | 0.00 | 0.00 | |
P/Operating CF |
— | — | 39.02 | (4.85) | |
P/B ratio |
— | — | 0.00 | 0.00 | |
Price to Tangible BV |
— | — | 0.00 | 0.00 | |
EV/Sales |
— | — | 11.89 | 15.04 | |
EV/EBITDA |
— | — | 0.00 | 0.00 | |
EV/Operating CF |
— | — | (1.45) | (1.71) | |
EV/FCF |
— | — | (1.44) | (1.70) | |
Quick Ratio |
0.03 | 0.00 | 0.08 | 0.09 | |
Current Ratio |
0.19 | 0.08 | 0.24 | 0.47 | |
Net Debt/EBITDA |
(6.30) | 0.19 | (1.24) | (0.38) | |
Debt/Assets |
211.30% | 142.44% | 130.28% | 53.02% | |
Debt/Equity |
(0.26) | (0.08) | (0.26) | (0.31) | |
Asset Turnover |
0.00 | 0.00 | 0.03 | 0.03 | |
Operating CF/Net income |
(0.04) | (0.43) | (0.09) | 0.43 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.27) | |
Interest Coverage |
(6.28) | (14.26) | (4.78) | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | (125.75%) | 18,489.49% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 4,768.56% | 16,504.67% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 4,153.12% | 1,245.14% | |
Graham Net Nets |
— | — | (1.06) | (0.53) | |
Graham Number |
— | — | 160.24 | 150.73 | |
Earnings Yield |
— | — | (208.31%) | (120.23%) | |
Free Cash Flow Yield |
— | — | (88.49%) | (67.52%) | |
Revenue per Share |
0.00 | 0.00 | 0.06 | 0.05 | |
Operating CF per Share |
(0.52) | 2.06 | 0.59 | (8.66) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.10) | |
Free Cash Flow per Share |
(0.52) | 2.06 | 0.59 | (8.76) | |
Cash per Share |
0.22 | 0.00 | 0.04 | 0.06 | |
Shareholders Equity per Share |
(10.81) | (31.42) | (23.92) | (20.00) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(10.81) | (31.42) | (23.92) | (20.00) | |
Free Cash Flow |
(0.38) | 1.21 | 0.37 | (4.98) | |
Working Capital |
(4.31) | (11.97) | (8.86) | (6.08) | |
Capital Expenditures |
— | — | 0.00 | (0.06) | |
Net Current Asset Value |
(7.97) | (18.48) | (15.19) | (12.55) | |
EV/EBIT |
— | — | 0.00 | 0.00 | |
Capex to Sales |
— | — | 0.00 | 2.22 | |
Price to Operating Income |
— | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
3.59 | 2.80 | 3.55 | 3.45 | |
Average Assets |
6.17 | 6.42 | 60.87 | 61.80 | |
Average Common Equity |
(6.09) | (8.29) | (9.94) | (7.82) |
Columns are period end dates